{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001479419","name":"KALA BIO, Inc.","summary":"KALA BIO, Inc. is a clinical-stage biopharmaceutical company focused on rare and severe ophthalmic diseases. Its lead candidate, KPI-012, is a mesenchymal stem cell secretome (MSC-S) in Phase 2b (CHASE trial) for persistent corneal epithelial defects (PCED). It previously commercialized EYSUVIS and INVELTYS, which were sold to Alcon in 2022. The company also has a preclinical program, KPI-014, targeting inherited retinal degenerative diseases.","people":[],"products":[{"name":"KPI-012","type":"platform","description":"Human bone-marrow derived MSC secretome in Phase 2b clinical trial for persistent corneal epithelial defects (PCED); holds FDA Orphan Drug and Fast Track designations."},{"name":"KPI-014","type":"platform","description":"Preclinical MSC-S platform program evaluating treatment of inherited retinal degenerative diseases such as Retinitis Pigmentosa and Stargardt Disease."},{"name":"EYSUVIS","type":"service","description":"Loteprednol etabonate ophthalmic suspension 0.25% for short-term treatment of dry eye disease; sold to Alcon in July 2022."},{"name":"INVELTYS","type":"service","description":"Loteprednol etabonate ophthalmic suspension 1% for post-operative ocular inflammation and pain; sold to Alcon in July 2022."}],"partnerships":[{"partner_name":"Alcon Pharmaceuticals Ltd. / Alcon Vision, LLC","partnership_type":"licensing","description":"Purchased rights to EYSUVIS, INVELTYS, and AMPPLIFY Drug Delivery Technology for $60M upfront plus up to $325M in sales milestones.","start_date":null},{"partner_name":"Combangio, Inc.","partnership_type":"acquisition","description":"Acquired KPI-012 MSC-S product candidate from Combangio on November 15, 2021.","start_date":null}],"affiliations":[],"origin":{"leaf":"fde06ee17b995315373875314cdb91655c0176caef3c7da60c87a82ff4d5eeb2","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"06575e8968d677a2c82219fe326e734ba4a10873d2cc3677cb5feb0cc3fedee6","parent":"b9c1721657272d71a8d15c19a6d40fe38ebc438a279926299ade85e037ad26f1","source":"0001558370-25-004081","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":11,"hourly_limit":500,"remaining":489,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}